The US Alcohol and Tobacco Tax and Trade Bureau (TTB) warned alcoholic drinks manufacturers to limit the use of the word "clean" to describe a flavor, not to imply health claims.
All alcoholic beverages must also bear a health risk warning, according to the TTB's existing labeling requirements, and the word "clean" isn't a method to soften that message.
The TTB admitted that its regulations do not define the word 'clean,' and that they do not have standards for the use of the term on labels or in advertisements.
It warned that consumers should not interpret the term as meaning that the beverage is organic or has met other production standards set by TTB.
The TTB noted that the word clean is being used along with other teams to create the misleading impression that consuming the alcoholic beverage will have health benefits, or that the health risks of alcohol consumption will be mitigated.


DOJ Opens Criminal Investigation Into E. Jean Carroll Over Alleged Perjury
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Bayer Rules Out Monsanto Spin-Off as Roundup Lawsuits Continue to Mount
CDC Confirms U.S. Ebola Case Linked to Congo Outbreak as Travel Restrictions Tighten
US Raises Concerns Over Possible ASML EUV Machine Transfer to China
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples
Kennedy Center Ordered to Remove Trump Name Following Federal Court Ruling
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
DOJ Sues Virginia Over Law Enforcement Mask Ban
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 



